Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study

[1]  Chen Li,et al.  Kupffer Phase Radiomics Signature in Sonazoid-Enhanced Ultrasound is an Independent and Effective Predictor of the Pathologic Grade of Hepatocellular Carcinoma , 2022, Journal of oncology.

[2]  Kai-yan Li,et al.  Evaluation of contrast-enhanced ultrasound LI-RADS version 2017: application on 271 liver nodules in individuals with non-alcoholic steatohepatitis , 2022, European Radiology.

[3]  Jian-Wei Wang,et al.  Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection. , 2022, AJR. American journal of roentgenology.

[4]  J. H. Kim,et al.  Diagnostic criteria of perfluorobutane-enhanced ultrasonography for diagnosing hepatocellular carcinoma in high-risk individuals: how is late washout determined? , 2021, Ultrasonography.

[5]  J. H. Kim,et al.  Diagnostic criteria of perfluorobutane-enhanced ultrasonography for diagnosing hepatocellular carcinoma in high-risk individuals: how is late washout determined? , 2021, Ultrasonography.

[6]  F. Izzo,et al.  Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review , 2021, World journal of gastrointestinal oncology.

[7]  Ming-de Lu,et al.  Contrast‐Enhanced Ultrasound for Differentiation Between Poorly Differentiated Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma , 2021, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[8]  Y. Chou,et al.  Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions , 2021, Abdominal Radiology.

[9]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[10]  T. Itoi,et al.  Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid , 2020, Diagnostics.

[11]  Jae Young Lee,et al.  Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. , 2020, Ultrasound in medicine & biology.

[12]  M. Rugge,et al.  Diagnosis of digestive system tumours , 2020, International journal of cancer.

[13]  J. Lee,et al.  Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid , 2020, Abdominal Radiology.

[14]  C. Sirlin,et al.  LI-RADS ancillary features on contrast-enhanced ultrasonography , 2020, Ultrasonography.

[15]  B. Choi,et al.  The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid , 2020, Ultrasonography.

[16]  Jian-Wei Wang,et al.  Evaluation of Contrast-enhanced US LI-RADS version 2017: Application on 2020 Liver Nodules in Patients with Hepatitis B Infection. , 2019, Radiology.

[17]  Y. Chawla,et al.  Rupture of Hepatocellular Carcinoma: A Review of Literature. , 2019, Journal of clinical and experimental hepatology.

[18]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[19]  A. Furlan,et al.  Mosaic architecture of hepatocellular carcinoma , 2018, Abdominal Radiology.

[20]  Han Zhang,et al.  Surgical options for intrahepatic cholangiocarcinoma. , 2017, Hepatobiliary surgery and nutrition.

[21]  Masatoshi Kudo,et al.  Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment , 2016, Liver Cancer.

[22]  L. Beretta,et al.  Quantitative Contrast-Enhanced Ultrasonic Imaging Reflects Microvascularization in Hepatocellular Carcinoma and Prognosis after Resection. , 2015, Ultrasound in medicine & biology.

[23]  M. Moriyama,et al.  Quantitative sonographic image analysis for hepatic nodules: a pilot study , 2015, Journal of Medical Ultrasonics.

[24]  M. Colombo,et al.  Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[25]  Junji Shiraishi,et al.  Comparison of Kupffer‐Phase Sonazoid‐Enhanced Sonography and Hepatobiliary‐Phase Gadoxetic Acid‐Enhanced Magnetic Resonance Imaging of Hepatocellular Carcinoma and Correlation With Histologic Grading , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[26]  M. Manns,et al.  Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective study. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[27]  H. Waki,et al.  Definition of contrast enhancement phases of the liver using a perfluoro-based microbubble agent, perflubutane microbubbles. , 2009, Ultrasound in medicine & biology.

[28]  Isao Sakaida,et al.  Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images , 2009, Journal of Gastroenterology.

[29]  Kinuyo Hatanaka,et al.  Sonazoid-Enhanced Ultrasonography for Diagnosis of Hepatic Malignancies: Comparison with Contrast-Enhanced CT , 2008, Oncology.

[30]  T. Kim,et al.  Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. , 2007, Radiology.

[31]  Fuminori Moriyasu,et al.  Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. , 2007, Ultrasound in medicine & biology.

[32]  C. Baird.  The pilot study. , 2000, Orthopedic nursing.

[33]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[34]  Yingjie Zhang,et al.  Enhancement Patterns of Intrahepatic Cholangiocarcinoma on Contrast-Enhanced Ultrasound: Correlation with Clinicopathologic Findings and Prognosis. , 2019, Ultrasound in medicine & biology.

[35]  N. Tait,et al.  Hepatic Dystychoma: A Five Year Experience , 1991, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.